<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>Tobacco Articles: org scotus</title>
<link>http://www.tobacco.org/newsfeed/org/scotus.rss</link>
<description>Latest top tobacco news headlines</description>
<language>en-us</language>
<item>
<title>'Lights' out? ($$): Troy attorney takes fight against purportedly mislabeled tobacco products to U.S. Supreme Court</title>
<link>http://www.milawyersweekly.com/subscriber/archives_FTS.cfm?page=mi/08/8250843.htm</link>
<guid>http://tobacco.org/news/270650.html</guid>
<description>Troy lawyer Gerard V. Mantese is taking on the tobacco industry.
 . . .

Now, with a lawsuit against Philip Morris pending before the U.S. Supreme Court, Mantese has his chance to do just that.

&quot;In 2004, I put together a consortium of law firms in several states ... with the goal of representing consumers who were defrauded by Philip Morris [when it] falsely represented that its Marlboro Lights had 'lowered tar and nicotine,'&quot; he explained.

Since then, Mantese has filed lawsuits in Maine, Arkansas and New Mexico accusing Phillip Morris of violating each state's prohibition against deceptive advertising.

&quot;All of the cases are based on the same theory: Philip Morris misrepresented the true nature of its so-called 'light' cigarettes [because] it represented that they contained lower [amounts of] tar and nicotine ... when a multitude of data, internal documents and evidences proves otherwise,&quot; he said.

One case, Altria Group,  et al., v. Good, et al., has landed Mantese before the U.S. Supreme Court.</description>
<source url="http://www.milawyersweekly.com/">Michigan Lawyers Weekly</source>
<pubDate>Mon, 25 Aug 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>Docket for 07-562: ALTRIA v. GOOD</title>
<link>http://origin.www.supremecourtus.gov/docket/07-562.htm</link>
<guid>http://tobacco.org/news/270183.html</guid>
<description>Jul 8 2008 	Letter from the Acting Solicitor General received and distributed.

Aug 11 2008 	Reply of petitioners Altria Group, Inc., et al. filed. (Distributed)

Aug 18 2008 	Motion of the Acting Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED.

</description>
<source url="http://supremecourtus.gov/">Supreme Court of the United States</source>
<author>TOlson@gibsondunn.com</author>
<pubDate>Mon, 18 Aug 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title> A second blow to tobacco appeal</title>
<link>http://www.scotusblog.com/wp/a-second-blow-to-tobacco-appeal/</link>
<guid>http://tobacco.org/news/268485.html</guid>
<description>
In the pending Altria Group appeal in the Supreme Court, the &#8220;Cambridge Filter Method&#8221; &#8212; or &#8220;FTC Test&#8221; &#8212; is directly at issue.  The company argues that FTC policy actually requires tobacco companies to disclose tar and nicotine yields based on the test, and that the FTC has authorized the companies to advertise cigarettes by using words such as &#8220;light&#8221; as short-hand ways of referring to the test results.

 Because of these FTC &#8220;mandates,&#8221; as the company calls them, federal policy on cigarette marketing of &#8220;light&#8221; cigarettes bars states from allowing lawsuits in their courts challenging the use of such words or phrases, the appeal contends. . . .


In the federal brief filed last month, the U.S. Solicitor General&#8217;s office in the Justice Department, joined by the FTC, directly disputed the tobacco company&#8217;s claim that its ads on &#8220;light&#8221; cigarettes were the result of FTC &#8220;mandates.&#8221;

The Commission&#8217;s policy, in 1966 and since, has never required the companies to use ads that refer to the yields from the FTC Test, and has not authorized them to use &#8220;light&#8221; or other descriptive phrases as short-hand indications of the Test&#8217;s results.

The company&#8217;s claim that state court lawsuits are preempted by FTC policy, the brief said, &#8220;should be rejected because it is based on a mischaracterization of the scope and effect of FTC&#8217;s actions concerning cigarette advertising.&#8221;  . . .

  The FTC, the brief added, does not view state court lawsits like the one in Maine &#8220;as undermining the FTC&#8217;s policies in any way. . . .


The Solicitor General&#8217;s office on Tuesday notified the Court, by letter, of the FTC&#8217;s new proposal to drop its 1966 policy. Attached to the letter was the Commission&#8217;s Federal Register notice of its plan.

The tobacco company has gained added time, until Aug. 11, to file its reply brief; that will provide a chance to challenge not only the government brief, but also the impact, if any, of the FTC&#8217;s new approach.</description>
<source url="http://www.goldsteinhowe.com/blog/">SCOTUSBlog</source>
<author>scotusblog.feedback@gmail.com (Lyle Denniston )</author>
<pubDate>Wed, 09 Jul 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>Supreme Court cases could shield drug, tobacco companies from product liability lawsuits</title>
<link>http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D91HUHO06</link>
<guid>http://tobacco.org/news/268139.html</guid>
<description>
The case, along with a separate tobacco lawsuit against Altria Group Inc., centers on whether federal regulation of products overrides state laws, including those that govern when a person or company can be held liable for another's injury.


The court's ruling in the Wyeth case &quot;potentially could apply to all lawsuits against all manufacturers of prescription drugs,&quot; said Mark Herrmann, an attorney at Jones Day in Chicago who represents drug and medical device companies. &quot;It's the 800-pound gorilla.&quot;

That's because the vast majority of lawsuits against drugmakers involve the same issue: whether the company provided sufficient notice of potential hazards in the product's label. Pharmaceutical labels are approved by the Food and Drug Administration.

If the court issues a broad ruling in favor of Wyeth, other industries likely will follow suit</description>
<source url="http://hosted.ap.org/">AP</source>
<author>help@canadianbusiness.com (Christopher S. Rugaber)</author>
<pubDate>Thu, 26 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>Wider impact for punitive damages ruling? </title>
<link>http://www.lawyersusaonline.com/index.cfm/archive/view/id/431181</link>
<guid>http://tobacco.org/news/267866.html</guid>
<description>

The U.S. Supreme Court's decision to drastically slash a punitive damages award against Exxon over the 1989 Valdez oil spill from $2.5 billion to $500 million has lawyers debating whether the ruling will have an impact on punitive damage awards beyond maritime cases. . . .



The Court held in a 5-3 decision that an appropriate punitive damages award should not exceed an amount equal to the compensatory damages in the case, which totaled $507.5 million.

However, the Court relied heavily on an analysis of punitive damages generally.

Some attorneys say the case has widespread implications.</description>
<source url="http://www.lawyersweekly.com/">Lawyers Weekly USA</source>
<author>sylvia.hsieh@lawyersusaonline.com (Sylvia Hsieh Staff writer)</author>
<pubDate>Mon, 30 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>UPDATE:US Supreme Court Orders Reduction In Exxon Valdez Award</title>
<link>http://money.cnn.com/news/newsfeeds/articles/djf500/200806251058DOWJONESDJONLINE000613_FORTUNE5.htm</link>
<guid>http://tobacco.org/news/267575.html</guid>
<description>The U.S. Supreme Court Wednesday said punitive damages are allowed in a lawsuit over the 1989 Valdez oil spill by a 5-3 vote but ordered lower courts to reduce the $2.5 billion award to no more than $507.5 million.

Justice David Souter, in the court's majority opinion, said the punitive damages award should be brought into line with compensatory damages calculations made by lower courts earlier in the litigation.

&quot;The award here should be limited to an amount equal to compensatory damages,&quot; Souter wrote, adding the high court ruling endorses a $507.5 million amount calculated by a federal trial judge in 2002. The original award in the lawsuit, not including interest and other costs, was $287 million.

The high court otherwise split evenly 4-4 on an important maritime law question in the case as a majority concluded that federal environmental laws don't bar punitive damages against the oil giant.

Chief Justice John Roberts Jr. and Justices Antonin Scalia, Anthony Kennedy and Clarence Thomas joined Souter in the majority holding limiting the punitive damages. Justices John Paul Stevens, Ruth Bader Ginsburg and Stephen Breyer dissented, saying the court went too far in restricting punitive damages to a one-to-one ratio with compensatory damages.</description>
<source url="http://www.tobacco.org/media.php?mode=display&amp;media_id=13478">Dow Jones via Nasdaq</source>
<pubDate>Wed, 25 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>Exxon Valdez Award Cut to $507.5 Million by Top Court (Update2)</title>
<link>http://www.bloomberg.com/apps/news?pid=20601087&amp;sid=atrlmOYWL3fI&amp;refer=home</link>
<guid>http://tobacco.org/news/267574.html</guid>
<description>A divided U.S. Supreme Court slashed the $2.5 billion punitive damage award against Exxon Mobil Corp. for the 1989 Valdez oil spill to $507.5 million, ending a 19-year legal saga over the worst such disaster in U.S. history.

The justices, voting 5-3, said the original award, which would have been increased by more than $2 billion with accrued interest, was excessive under federal maritime law. The $507.5 million figure is equal to the economic damages that a trial judge determined were suffered by thousands of Alaskan commercial fishermen involved in the case.

Writing for the court, Justice David Souter pointed to studies showing that punitive damages awarded in maritime cases were generally less than the amount of compensatory damages.


``A 1:1 ratio, which is above the median award, is a fair upper limit in such maritime cases,'' Souter wrote. . . .


The court divided largely along ideological lines. Chief Justice John Roberts and Justices Antonin Scalia, Clarence Thomas and Anthony Kennedy joined Souter in the majority. Justices John Paul Stevens, Ruth Bader Ginsburg and Stephen Breyer dissented.</description>
<source url="http://www.tobacco.org/media.php?mode=display&amp;media_id=1574">Bloomberg News</source>
<author>gstohr@bloomberg.net (Greg Stohr)</author>
<pubDate>Wed, 25 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>OCTOBER TERM 2008 (PDF): For the Session Beginning October 6, 2008 </title>
<link>http://www.supremecourtus.gov/oral_arguments/argument_calendars/MonthlyArgumentCalOctober2008.pdf</link>
<guid>http://tobacco.org/news/267479.html</guid>
<description>Court convenes at 10 a.m.;  . . . 

Monday, October 6

(1)

07-562 ALTRIA GROUP, INC. V. GOOD</description>
<source url="http://supremecourtus.gov/">Supreme Court of the United States</source>
<pubDate>Mon, 23 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>ALTRIA v. GOOD - BRIEF OF AMICUS CURIAE CONSTITUTIONAL AND ADMINISTRATIVE LAW SCHOLARS IN SUPPORT OF RESPONDENTS (PDF)</title>
<link>http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/07-562_RespondentAmCuConLawAdminLawScholars.pdf</link>
<guid>http://tobacco.org/news/267478.html</guid>
<description>Current constitutional doctrine affords Congress broad authority to preempt state law. If meaningful balance in our federal system is to be preserved, the courts must not overread the preemptive scope of the legislation that Congress enacts. It is for Congress, not the federal courts, to expand the preemptive force of federal regulation into areas of health and safety regulation that have long been subjects of state authority. And courts must be particularly careful not to accord preemptive force to action by federal agencies-which elude both the political and procedural safeguards of federalismexcept when such agencies are either interpreting Congress's statutes or acting within clear delegations of authority to act with the force of law. In this case, these principles require Respondents' state law claims to go forward.
</description>
<source url="http://www.abajournal.com/">ABA Journal </source>
<pubDate>Mon, 23 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>ALTRIA v. GOOD - BRIEF OF AMICI CURIAE MARYLAND CONSUMER RIGHTS COALITION AND LEGAL RESOURCE CENTER FOR TOBACCO REGULATION, LITIGATION &amp; ADVOCACY IN SUPPORT OF RESPONDENTS (PDF)</title>
<link>http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/07-562_RespondentAmCuMDConsumerRightsCoalition.pdf</link>
<guid>http://tobacco.org/news/267477.html</guid>
<description>SUMMARY OF ARGUMENT
 . . .

A plurality of this Court made clear in Cipollone
v. Liggett Group, Inc. that a claim of fraud or
misrepresentation premised on a cigarette manufacturer&#8217;s
duty not to deceive consumers is not preempted
by the Federal Cigarette Labeling and Advertising
Act (&#8220;FCLAA&#8221;). Cipollone held that while
some state law claims alleging deception in the advertising
and promotion of cigarettes are preempted
by the FCLAA, some claims are not preempted. The
critical factor in determining whether a claim is
preempted is the predicate duty upon which a claim
is based. Causes of action that allege warning neutralization
or constitute failure to warn are preempted;
those that are based on the cigarette manufacturer&#8217;s
duty not to deceive are not preempted.
Based on the MUTPA&#8217;s imposition of a general duty
to not deceive on all commercial actors in Maine,
Good&#8217;s claims are not preempted by the FCLAA.
To construe the FCLAA or Cipollone in any other
manner would result in immunity for cigarette manufacturers
to deceive consumers on matters that concern
smoking and health. Given the explicit documentation
of PMUSA&#8217;s deception in the advertising and
promotion of its light and low tar and nicotine cigarettes,
allowing Good to pursue her consumer fraud
claims will result in an equitable and legally sound
outcome.
</description>
<source url="http://www.abajournal.com/">ABA Journal </source>
<pubDate>Wed, 18 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>ALTRIA v. GOOD - BRIEF OF AMICI CURIAE TOBACCO CONTROL LEGAL CONSORTIUM, AARP, AND PUBLIC JUSTICE IN SUPPORT OF RESPONDENTS (PDF)</title>
<link>http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/07-562_RespondentAmCuTCLCAARPPubJustice.pdf</link>
<guid>http://tobacco.org/news/267476.html</guid>
<description>SUMMARY OF ARGUMENT

Amici file this brief to emphasize a point that may
not stand out in respondents&#8217; more comprehensive
treatment of the issues before the Court &#8212; namely,
that there is no hint in either the Labeling Act or in
the FTC&#8217;s on-again, off-again actions regarding
disclosure of cigarettes&#8217; tar and nicotine content that
Congress or the FTC intended to &#8220;insulate [cigarette]
manufacturers from longstanding rules governing
fraud.&#8221; Cipollone, 505 U.S. at 528-29.
Make no mistake, this case is about fraud. As the
United States argued in its civil racketeering action
against Philip Morris and other cigarette companies,
&#8220;marketing of &#8216;light&#8217; cigarettes is a principal weapon in
their attempts to mislead the public regarding the
health risks of smoking.&#8221; Brief for the United States in
United States v. Philip Morris, et al., No. 06-5267, et
al., at 146 (D.C. Cir. filed Nov. 19, 2007). The question
in this case is whether petitioners are shielded from
state anti-fraud litigation because Congress or the FTC
preempted fraud claims arising from statements made
to deceive smokers that &#8220;light&#8221; cigarettes are less
deadly than regular cigarettes. The answer to that
question is &#8220;no.&#8221;

To be sure, this Court in Cipollone held that the
Labeling Act preempts state law claims that would
require cigarette companies to add or modify the
warnings prescribed by Congress. But Cipollone also
held that the Labeling Act does not preempt claims
arising from false statements made in advertising,
press statements, government submissions and other
channels of communication, where the claim is based
on the duty not to deceive. 505 U.S. at 528, 529
(plurality). Thus, allegations that a cigarette company
deliberately misrepresented and concealed material
facts in violation of a state anti-fraud statute &#8212; the
precise allegations at issue here &#8212; are not preempted.
Id. As the plurality saw it, Congress did not intend the
Labeling Act &#8220;to insulate cigarette manufacturers from
longstanding rules governing fraud.&#8221; Id. Such claims
are not predicated on a duty &#8220;based on smoking and
health,&#8221; but on a general duty imposed by state law &#8212;
i.e., the duty not to deceive. Id. at 528-89. Petitioners&#8217;
theory should be rejected because it would, contrary to
Congress&#8217; intent, effectively insulate cigarette
manufacturers from rules governing fraud, no matter
how egregious the manufacturers&#8217; false statements or
fraudulent concealment.
Equally insubstantial is petitioners&#8217; argument that
the FTC &#8220;authorized&#8221; tobacco companies to use &#8220;Light&#8221;
as a product descriptor (Marlboro Lights), and that
permitting respondents&#8217; claims to go forward &#8220;would
impede the FTC&#8217;s low-tar policy.&#8221; Br. at 46. The
signal defect in petitioners&#8217; argument is that the FTC
itself disclaims the existence of any authorization or
policy, let alone a policy that justifies ousting
longstanding state anti-fraud laws. Even Philip
Morris has acknowledged elsewhere that there is no
such policy. In 2002, Philip Morris filed a petition with
the FTC urging the agency &#8220;to promulgate rules
governing . . . the use of descriptors such as &#8216;light&#8217; and
&#8216;ultra light.&#8217;&#8221; See Good, 501 F.3d at 56 n.29. Philip
Morris&#8217; petition, of course, would have been
superfluous had the FTC previously &#8220;authorized&#8221; the
use of these descriptors.

Just as fundamentally, the hodge-podge of FTC
actions cited by the Philip Morris as evidence of a
federal policy on light cigarettes could not have the
sweeping preemptive effect it claims. Because the
FTC&#8217;s mission of protecting consumers against unfair
and deceptive advertising practice overlaps with state
law, Congress established regulatory procedures for
the FTC to follow when it intends to take preemptive
action. See, e.g., American Financial Servs. Ass&#8217;n v.
FTC, 767 F.2d 957, 989-90 (D.C. Cir. 1985). The FTC
did not avail itself of those procedures here, which
further confirms the FTC&#8217;s position that it did not act
to preempt state law. For these reasons as well,
petitioners&#8217; implied preemption argument should be
rejected.

The Labeling 4 Act&#8217;s preemption provision states that
&#8220;[n]o requirement or prohibition based on smoking and
health shall be imposed under State law with respect to the
advertising or promotion of any cigarettes the packages of
which are labeled in conformity with the provisions of this
chapter.&#8221; 15 U.S.C. &#167; 1334(b). Those provisions require
that packages of cigarettes and their advertisements bear
one of a rotating series of warnings about the adverse
health effects of smoking. Id. &#167; 1333(a), (c). The Act also
provides that no additional &#8220;statement relating to smoking
and health . . . shall be required on any cigarette package.&#8221;
Id. &#167; 1334(a).
</description>
<source url="http://www.abajournal.com/">ABA Journal </source>
<pubDate>Wed, 18 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>ALTRIA v. GOOD - BRIEF OF 48 STATES (PDF)</title>
<link>http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/07-562_RespondentAmCu48States.pdf</link>
<guid>http://tobacco.org/news/267464.html</guid>
<description>QUESTIONS PRESENTED

1. Whether the Federal Cigarette Labeling and
Advertising Act expressly preempts state-law claims
that a cigarette company violated the Maine Unfair
Trade Practices Act by falsely representing its &#8220;light&#8221;
cigarettes to the public when the predicate state-law
duty of such claims is the duty not to deceive.

2. Whether such claims are impliedly preempted
where the FTC has never exercised its rulemaking
power to address the conduct at issue nor
defined the terms at issue in this dispute. . . .

SUMMARY OF ARGUMENT

This case presents the questions whether the
FCLAA or the actions of the FTC preempt state-law
deception claims arising out of Petitioners&#8217; practices
with respect to &#8220;low tar and nicotine&#8221; and &#8220;light&#8221;
cigarettes. Neither the FCLAA nor the actions of the
FTC license Petitioners to deceive consumers in
violation of state law. Immunizing Petitioners from
the consequences of the alleged wrongful conduct is
not a result that should be presumed without clear
language and intent, neither of which is present here.

1. In Cipollone v. Liggett, 505 U.S. 504 (1992),
the Court held that the FCLAA does not preempt
claims resting upon false representation of a material
fact or concealment of a material fact by tobacco
companies where such claims are founded upon a
general duty under state law not to deceive. The suit
at issue here brings precisely such claims. It seeks
economic, not personal injury, damages, under
Maine&#8217;s general prohibition against any &#8220;material
representation, omission, act or practice that is likely
to mislead consumers acting reasonably under the
circumstances.&#8221; Me. Rev. Stat. Ann. tit. 5, &#167; 207
(Supp. 2007). Because the lawsuit before the Court is
predicated upon a general statutory prohibition
against deception (that the manufacturers made false
statements and concealed information regarding
&#8220;light&#8221; cigarettes), under Cipollone it is not preempted.
To find otherwise would disrupt and do serious
harm to the sovereigns&#8217; complementary efforts to
protect consumers, which would have adverse implications
beyond the &#8220;light&#8221; cigarettes dispute before
the Court here. State law suits pursuant to state
unfair practices and consumer protection statutes
combating deceptive practices are a critical complement
to the administrative and prosecutorial efforts
of the FTC. In fact, recognizing that it cannot combat
consumer fraud on its own, FTC regulations direct
the agency &#8220;to assist and cooperate&#8221; with state consumer
protection efforts. One common outgrowth of
that cooperation is that the FTC and the States often
target the same wrongdoers, which sometimes results
in separate settlements that provide different forms
of relief. There is no exception in this complementary
regulatory scheme for fraud or deception by cigarette
manufacturers. Indeed, the FTC acknowledges the
States&#8217; vital part in prohibiting deception by tobacco
companies.

2. Petitioners&#8217; arguments that the FTC has
somehow impliedly preempted the state-law claims
are patently incorrect. Nothing in the text, structure,
or regulatory history of the FTC Act or in the actions
of the FTC relating to &#8220;light&#8221; cigarettes supports
implied preemption. Petitioners are not claiming that
the FTC Act itself imposes requirements on tobacco
companies that conflict with state law. Nor could they,
given that the FTC Act lacks an express preemption
provision and instead contains a broad saving clause
protecting state remedies and causes of action. In
addition, Congress imposed heightened requirements
for FTC rulemaking, and the FTC&#8217;s procedural rules
require that it explain the impact of any of its rules
on state law. And petitioners do not assert that the
FTC has promulgated specific rules that preempt
state-law actions with respect to &#8220;low tar&#8221; and &#8220;light&#8221;
cigarettes. Rather, Petitioners&#8217; implied preemption
claim is based on their assertion that the FTC has
blessed tobacco companies&#8217; &#8220;light&#8221; cigarette advertisements
through a history of less formal actions,
such as consent decrees reached with individual
companies. But neither the consent decrees nor the
other actions relied upon by Petitioners mandated or
approved Petitioners&#8217; &#8220;light&#8221; and &#8220;low tar&#8221; advertisements.
Moreover, in none of those actions did the FTC
ever suggest that State consumer protection laws
present an obstacle to, or are preempted by, some sort
of FTC policy. Indeed, the FTC has eschewed any
suggestion that its actions have resolved the issue of
tobacco companies&#8217; deceptive practices regarding &#8220;low
tar&#8221; cigarettes. . . .


* * *
The common purpose of the FTC Act and State
unfair trade practices and consumer protection acts,
such as Maine&#8217;s, is to protect consumers from deceptive
practices. The FTC has been most sensitive to
this relationship, as have the courts. Finding preemption
here would run counter to how the FTC and the
States have worked cooperatively together, and would
do serious harm to that relationship and to the protections
afforded consumers through their efforts. The
particular claims of deception here fall squarely
within those permitted under Cipollone, and the FTC
has not established a cohesive policy impliedly preempting
the States with respect to deceitful conduct
by tobacco companies regarding &#8220;low tar&#8221; and &#8220;light&#8221;
cigarettes. For these reasons, the Court should find
that the state-law claims before it are not preempted.


</description>
<source url="http://www.abajournal.com/">ABA Journal </source>
<pubDate>Wed, 18 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>ALTRIA v. GOOD - BRIEF OF ALLAN M. BRANDT, ROBERT N. PROCTOR, DAVID M. BURNS, JOHNATHAN M. SAMET, AND DAVID ROSNER AS AMICI CURIAE SUPPORTING RESPONDENTS (PDF)</title>
<link>http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/07-562_RespondentAmCu5Profs.pdf</link>
<guid>http://tobacco.org/news/267463.html</guid>
<description>CONCLUSION 
Philip Morris voluntarily markets Cambridge Light cigarettes and Marlboro Lights as &#8220;light&#8221; or &#8220;lowered in tar and nicotine&#8221; without FTC control or direction. Thus, Respondents&#8217; claims are not impliedly preempted. For these reasons, and because Respondents&#8217; claims are not expressly preempted under the FCLAA, as discussed in Respondents&#8217; brief, this Court should affirm the First Circuit&#8217;s decision. 
</description>
<source url="http://www.abajournal.com/">ABA Journal </source>
<pubDate>Wed, 18 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>ALTRIA v. GOOD - BRIEF OF FORMER COMMISSIONERS  OF THE FEDERAL TRADE COMMISSION  AS AMICI CURIAE  IN SUPPORT OF RESPONDENTS (PDF)</title>
<link>http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/07-562_RespondentAmCuFmrFTCCommissioners.pdf</link>
<guid>http://tobacco.org/news/267462.html</guid>
<description>CONCLUSION 

The FTC&#8217;s primary mission as a law enforcement
agency is to enforce the FTC Act&#8217;s Section 5 prohibition
against unfair or deceptive conduct in commerce,
rather than to give broad immunity to an industry
from state police power. See 15 U.S.C. &#167; 45(a)(2)
(&#8220;The Commission is hereby empowered and directed
to prevent persons, partnerships, or corporations &#8230;
from using unfair methods of competition in or affecting
commerce and unfair or deceptive acts or practices
in or affecting commerce.&#8221;); Fleming  v.  FTC,
670 F.2d 311, 313 (D.C. Cir. 1982) (Commission&#8217;s
mandate is &#8220;to ferret out any unfair competition and
unfair or deceptive trade acts or practices in or affecting
commerce&#8221; ). Nothing in the FTC&#8217;s regulatory
history suggests an intent to authorize, encourage, or
immunize Petitioners&#8217; use of lights descriptors. The
judgment of the court of appeals should be affirmed.</description>
<source url="http://www.abajournal.com/">ABA Journal </source>
<pubDate>Wed, 18 Jun 2008 04:00:00 GMT</pubDate>
</item>

<item>
<title>ALTRIA v. GOOD - BRIEF FOR THE UNITED STATES AS AMICUS CURIAE SUPPORTING RESPONDENTS (PDF)</title>
<link>http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/07-562_RespondentAmCuUSA.pdf</link>
<guid>http://tobacco.org/news/267460.html</guid>
<description>BRIEF FOR THE UNITED STATES AS AMICUS CURIAE SUPPORTING RESPONDENTS

WILLIAM BLUMENTHAL
General Counsel
Federal Trade Commission
Washington, D.C. 20580
GREGORY G. GARRE
Acting Solicitor General
Counsel of Record
EDWIN S. KNEEDLER
Deputy Solicitor General
MICHAEL F. HERTZ
Deputy Assistant Attorney
General
DOUGLAS HALLWARD-DRIEMEIER
Assistant to the Solicitor
General
MARK B. STERN
ALISA B. KLEIN
Attorneys
Department of Justice
Washington, D.C. 20530-0001
(202) 514-2217
(I)

QUESTION PRESENTED

The Federal Trade Commission has authority to
prevent &#8220;unfair or deceptive acts or practices in or
affecting commerce,&#8221; 15 U.S.C. 45(a)(2), and the Federal
Trade Commission Act expressly provides that its
remedies &#8220;are in addition to, and not in lieu of, any other
remedy or right of action provided by State or Federal
law,&#8221; 15 U.S.C. 57b(e). The United States will address
the following question:

Whether guidance statements and consent orders
issued by the Federal Trade Commission impliedly preempt
a state-law tort claim based on a cigarette manufacturer&#8217;s
allegedly fraudulent use of the descriptors
&#8220;Light&#8221; and &#8220;Lowered Tar and Nicotine&#8221; to characterize
its cigarettes when the manufacturer allegedly knew
that the cigarettes, as smoked by a human smoker,
would deliver as much tar and nicotine as so-called &#8220;full
flavor&#8221; cigarettes. . . .



3. Petitioner failed for decades to disclose to the
FTC its internal research indicating that, due to compensatory
behaviors, smokers receive as much tar from
cigarettes with lower Cambridge Method ratings than
so-called &#8220;full-flavor&#8221; cigarettes. After hiding its own
research for years, despite the Commission&#8217;s requests
for information in light of growing concerns about compensation,
petitioner now claims that the FTC has
known about compensation for years and affirmatively
decided that it does not warrant any change in the Cambridge
Method. In fact, the absence of definitive action
on that question to date reflects only the Commission&#8217;s
ongoing consideration of the issue. Its inaction (particularly
insofar as it is based on petitioner&#8217;s own failure to
provide information to the FTC) does not constitute
even a definitive interpretation of the federal Act, much
less one that would bar application of state law.

ARGUMENT

RESPONDENTS&#8217; CLAIMS ARE NOT IMPLIEDLY PREEMPTED BY THE FEDERAL TRADE COMMISSION&#8217;S ACTIONS CONCERNING CIGARETTE ADVERTISING
</description>
<source url="http://www.abajournal.com/">ABA Journal </source>
<pubDate>Mon, 23 Jun 2008 04:00:00 GMT</pubDate>
</item>

</channel>
</rss>